November 20, 2017
UC Davis MIND Institute esearchers have shown in a mouse model that an elevated maternal immune response changes the epigenetic landscape in offspring’s microglia, immune cells found in the brain and spinal cord. These changes affect genes associated with immune signaling and neural development, some of which have been implicated in autism spectrum disorder (ASD). The study was published online in the journal Glia.
November 6, 2017
A startup company founded by a University of California, Davis, neuroscientist is developing video games that act as “digital medicine” to treat children with cognitive impairments, as well as people with cognitive limitations resulting from brain injury or aging. The company, Cognivive, is built on research by co-founder Tony Simon, professor of psychiatry and behavioral sciences at UC Davis, and others showing that playing action video games can enhance players’ spatiotemporal cognitive abilities.
November 6, 2017
The 2017-2018 Spanish Minds Behind the MIND lecture series kicks off on Thursday, Nov. 16 at 5:30 p.m. at the UC Davis MIND Institute, 2825 50th Street in Sacramento.
October 25, 2017
The UC Davis MIND Institute will host Joshua Gordon on Wednesday, Nov. 8 as part of the ongoing Distinguished Lecturer Series. Gordon, director, National Institute of Mental Health, will present “A neural circuit approach to mental illness” at 4:30 p.m. at the MIND Institute Auditorium, 2825 50th St. in Sacramento. This event is open to the public, and no reservations are required. A 30-minute question-and-answer session will follow the hour-long lecture.
October 24, 2017
October 23, 2017
Research conducted in mice at the UC Davis MIND Institute suggests that a drug treatment can reverse cognitive deficits and social abnormalities in a rare genetic disorder, 16p11.2 deletion syndrome, which includes symptoms of intellectual disability and autism spectrum disorder, among others. Results of parallel studies conducted at the MIND and at the Massachusetts Institute of Technology Picower Institute for Learning and Memory appear in the latest issue of the journal Neuropsychopharmacology.
October 4, 2017
The UC Davis MIND Institute kicks off its 2017-2018 Distinguished Lecturer Series this month with Urs Meyer, pharmacology professor at the University of Zurich. Meyer’s presentation, “Maternal Infection and Immunity in Neurodevelopmental Disorders,” will take place Wednesday, Oct. 11 at 4 p.m. at the MIND Institute, 2825 50th St. in Sacramento. This event is open to the public and no reservations are required.
October 3, 2017
UC Davis Children's Hospital, UC Davis Comprehensive Cancer Center and the UC Davis Genome Center are hosting the 2017-2018 Human Genomics Seminar Series, a monthly series focusing on genomic medicine topics, led by UC Davis faculty. Seminars will be held the first Wednesday of every month at noon at the Center for Health and Technology, room 1341.
September 25, 2017
The Center for Excellence in Developmental Disabilities (CEDD), part of the UC Davis MIND Institute, will host “Sus Derechos de Educación Especial” (Special Education Rights and Assessments) on Saturday, Sept. 30 at the MIND Institute auditorium, 2825 50th St. in Sacramento. The lecture will be given by multicultural affairs advocate Vanessa Ochoa and client rights advocate Brittnee Gillespie, both of Disability Rights California.
September 7, 2017
The UC Davis MIND Institute has been awarded a 5-year, $12 million Autism Centers of Excellence (ACE) grant, one of five in the nation, to create a “Center for the Development of Phenotype-based Treatments of Autism Spectrum Disorder.”
August 11, 2017
Julie Schweitzer, a professor in the Department of Psychiatry and Behavioral Sciences and UC Davis MIND Institute researcher, has received a $3.7 million grant from the National Institute of Mental Health (NIMH) to track impulsivity and self-control in teens and young adults over time.
July 10, 2017
The little brown-haired girl looked shyly at the man behind the counter at the café and took a breath.
June 23, 2017
The UC Davis MIND Institute has received a 3-year, $1.4 million grant to study how to build a statewide network to improve use of evidence-based practices for students with autism spectrum disorders (ASDs).
June 22, 2017
Researchers at the UC Davis MIND Institute and Boston Children’s Hospital have confirmed that mice without the Shank3B protein model aspects of brain physiology and behavioral symptoms observed in people with autism. The findings confirm that Shank3B knockout mice provide a valuable research tool for future efforts to develop new therapies. The study, supported by Autism Speaks, was published in the journal Molecular Autism.
June 7, 2017
Amori Mikami, associate professor and clinical psychologist at the University of British Columbia, will speak about ways to increase inclusion of children with attention-deficit/hyperactivity disorder (ADHD) in peer groups at a free public lecture June 14 at 4:30 p.m. at the UC Davis MIND Institute, 2825 50th St. in Sacramento.
May 8, 2017
Researcher and child neurologist Mustafa Sahin will speak about the relationship between the genetic disease tuberous sclerosis complex (TSC) and autism in a free public lecture on May 17 at 4:30 p.m. at the UC Davis MIND Institute, 2825 50th Street in Sacramento.
May 4, 2017
The UC Davis MIND Institute open house will be held Saturday, May 6 from 11 a.m. to 1 p.m. and reservations are still available.
April 17, 2017
While medication is a common treatment for adults who suffer from bipolar disorder, not much research has been done on this treatment in pediatric patients – until now.
April 7, 2017
Adults with autism spectrum disorder (ASD) will be the topic of the next Minds behind the MIND lecture on April 19 at 5:30 p.m. at the UC Davis MIND Institute, 2825 50th St. in Sacramento. The lecture is free and open to the public.
April 5, 2017
April is Autism Awareness Month, and the UC Davis MIND Institute has several events planned to help increase understanding of and provide resources to families affected by the disorder. All events will be held at the MIND Institute, 2825 50th St. in Sacramento.
April 4, 2017
Anxiety and autism are often key features of children with fragile X syndrome, but are not always identified early in life when treatments may be most effective.
March 6, 2017
Researchers from the UC Davis MIND Institute, University of North Carolina (UNC) and other institutions have found that altered distribution of cerebrospinal fluid (CSF) in high-risk infants can predict whether they will develop autism spectrum disorder (ASD). The study appears today in the journal Biological Psychiatry.
March 2, 2017
Professor and researcher Theo Palmer will speak about the relationship between maternal illness and autism genes in a free public lecture on March 8 at 4:30 p.m. at the UC Davis MIND Institute, 2825 50th Street in Sacramento.
UC Davis computational molecular biologist named Sloan fellow to study genetic causes of complex disorders
February 27, 2017
Fereydoun Hormozdiari, an early-career UC Davis scientist, has been named a 2017 Alfred P. Sloan Research Fellow in Computational & Evolutionary Molecular Biology. He is one of 126 scholars to receive the prestigious award, which comes with $60,000 over two years to conduct leading-edge research.
February 24, 2017
Aubyn Stahmer, director of community-based treatment research at the UC Davis MIND Institute, has received a grant from the National Institute of Mental Health to study different ways to support training to providers who treat children with autism spectrum disorder (ASD).
February 21, 2017
In two recent studies, researchers at UC Davis have shown that the placenta can provide critical information about early changes to the intra-uterine environment that may influence fetal development and ultimately, children’s brains.
January 31, 2017
Researchers at UC Davis have published a study that illustrates how maternal immune activation could affect neurodevelopment in offspring.
January 3, 2017
New York Times bestselling author and autism advocate John Elder Robison will speak on “Life with Autism” in a free public lecture on Jan. 11 at 4:30 p.m. at the UC Davis MIND Institute, 2825 50th St. in Sacramento.
December 28, 2016
The UC Davis MIND Institute is participating in a nationwide ADHD study using a scientifically designed video game-like technology.
December 15, 2016
The UC Davis MIND Institute and Rush University Medical Center have been awarded $11.5 million from the National Institutes of Health to test a new therapy designed to improve language learning for children fragile X syndrome.
December 13, 2016
Researchers at UC Davis have shown that a well-known neurotoxin (PCB 95) and a chromosomal duplication (Dup15q) have a profound impact on DNA methylation, the epigenetic process that can influence gene activity. These cumulative genetic and environmental “hits” alter the epigenetic landscape during development, altering genes linked to autism spectrum disorder (ASD). The study was published in the journal Cell Reports.